M
- MAC: factors affecting
- Magnesium complications
- Magnesium: Hypotensive effect
- Magnesium: side effects
- Mainstem Intub: Physiologic effects
- Malignant hyperthermia – Periop mgmt
- Malignant hyperthermia: Associated disorders
- Malignant hyperthermia: Signs
- Management: acute heart failure
- Management: lumbosacral radiculopathy
- Mannitol – Hemodynamic effects
- Mannitol osmolarity effects
- MAO inhibitor: meperidine toxicity
- Mapleson D: Rebreathing
- Mask CPAP: Physiologic effects
- Maternal mortality causes
- Maternal physiology – Blood volume
- Maximum ABL calculation
- Mechanical ventilation: Renal effects
- Mechanism of action: p450
- Meconium aspiration
- Meconium aspiration: Rx
- Meconium: Tracheal suctioning
- Mediastinal mass: CXR
- Mediastinal tumor: Airway obstruction
- Mediastinoscopy: vascular compression
- Meningomyelocele: Arnold-Chiari assoc
- Meperidine – Renal Failure
- Metabolic alkalosis: Respiratory compensation
- Metabolism – Meperidine
- Metformin – Complications
- Metformin – Periop mgmt
- Metformin: Contrast dye
- Metformin/Contrast dye interaction
- Methadone treatment management
- Methadone: QT interval
- Methemoglobinemia
- Methemoglobinemia: diagnosis
- Methemoglobinemia: Treatment
- Metoclopramide: esophageal sphincter tone
- Metoclopramide: gastric effects
- Metoclopramide: Pharm effects
- Meyer Overton correlation
- Mgmnt of hypoxemia during OLV
- Mgmt – WPW
- Mgmt difficult airway – Obese pt
- MgSO4: Cardiac effects
- MH vs. thyroid storm
- Midazolam: Bioavailability versus Route
- Midazolam: Peds oral dosage
- Milrinone: CV effects
- Milrinone: pharmacology
- Misfilled vaporizer: Output calc
- Mitral insufficiency: medical management
- Mitral Insufficiency: Pharmacologic Treatment
- MOCA requirements
- Moderate sedation: ASA guidelines
- Monitored anesthesia care: Requirements
- Monitoring for residual NMB
- Monitoring: barbiturate coma
- Morbid obesity – Drug dosing
- Morbid obesity & atelectasis
- Morbid obesity: DVT
- Morbid obesity: Hypoxemia physiology
- Morbid obesity: PFTs
- Morbid Obesity: post-op complications
- Morbid obesity: rapid desaturation
- Motor evoked potentials: Anesth effec
- MRI – Monitoring hazards
- MRI monitors artifacts
- MRI: Contraindications
- MRI: Thermal burns
- MRSA tx
- Multiple myeloma: Symptoms
- Multiple sclerosis – Risk of pulm comp
- Multiple sclerosis: exacerbation
- Multiple sclerosis: Periop mgmt
- Muscle relaxants – Benzodiazepine
- Muscle relaxants: Drug interactions
- Muscle relaxation: Anes agents
- Muscle relaxation: Mechanism
- Myasthenia gravis preop risk eval
- Myasthenia gravis: postop management
- Myasthenia: Muscle relaxant effects
- Myasthenia: physiology
- Myasthenic Synd vs Myas Gravis: Sx
- Myelomeningocele – Assoc anomalies
- Myocard ischemia intraop Dx/Rx
- Myocardial ischemia: Acute MR
- Myocardial ischemia: Beta-blockers
- Myocardial O2 consumption: determinants
- Myocyte repolarization: Ionic flow
- Myofascial pain syndrome: Dx
- Myofascial pain: diagnosis
- Myotonic dystrophy, intraop mgt
- Myotonic dystrophy: Aspiration risk
- Myotonic dystrophy: Preop eval
